The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up

Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecht, Robert, Hiebert, Lindsey, Spearman, Wendy C, Sonderup, Mark W, Guthrie, Teresa, Hallett, Timothy B, Nayagam, Shevanthi, Razavi, Homie, Soe-Lin, Shan, Vilakazi-Nhlapo, Kgomotso, Pillay, Yogan, Resch, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894072/
https://www.ncbi.nlm.nih.gov/pubmed/29529282
http://dx.doi.org/10.1093/heapol/czy018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894072/
https://www.ncbi.nlm.nih.gov/pubmed/29529282
http://dx.doi.org/10.1093/heapol/czy018

Ejemplares similares